Rivus snags $132M for potential NASH drug
 

Today's Big News

Sep 22, 2022
 
 

GSK plays the white knight, paying $66M to rescue Spero's oral antibiotic after FDA rejection

Servier severs CAR-T collab with Allogene, handing back rights outside the US to 3 candidates

Rivus raises $132M series B as obesity, NASH prospects for metabolic drug heat up

FDA slaps hold on DBV peanut allergy trial in call for protocol changes

Small molecule stimulates axon growth in mice with severe spinal cord injury

 
 

Featured

 
 

GSK plays the white knight, paying $66M to rescue Spero's oral antibiotic after FDA rejection

GSK is riding to the rescue of Spero Therapeutics’ oral antibiotic prospect, paying $66 million upfront for near-global rights to a drug candidate that needs to undergo another phase 3 trial following its recent rejection by the FDA. Spero is studying the drug as a treatment for complicated urinary tract infections.
 
 
 
 
 

Top Stories

 
 

Servier severs CAR-T collab with Allogene, handing back rights outside the US to 3 candidates

CAR-T therapies targeting CD19 might be considered a hot ticket in biotech, but that hasn’t stopped French pharmaceutical research company Servier from scrapping its collaboration with Allogene Therapeutics.
 
 
 

Rivus raises $132M series B as obesity, NASH prospects for metabolic drug heat up

After a data drop earlier this year, investors are showing their support for Rivus Pharmaceuticals’ metabolic disorder treatment pipeline, flushing the biotech with $132 million—nearly $100 million more than its first financing round.
 
 
 

FDA slaps hold on DBV peanut allergy trial in call for protocol changes

The FDA has grounded DBV Technologies’ latest phase 3 peanut allergy clinical trial before it even had a chance to take flight. Just weeks after DBV trumpeted the finalization of the protocol, the FDA has placed a partial clinical hold on the study and requested changes to the design of the study.
 
 
 

Small molecule stimulates axon growth in mice with severe spinal cord injury

A research team led by scientists from Imperial College London has successfully stimulated axon fiber regeneration in mice with severe spinal cord damage, a step forward in understanding and potentially developing therapies for patients with devastating injuries.
 
 
 

Alliance Pharma names 4 to C-suite positions amid expansion

Alliance Pharma has expanded its executive team with the addition of four c-suite hires as the bioanalytical services company continues its growth spurt.
 
 
 

New COVID-19 variant's spread draws concern from CDC

In the last two weeks, the BF.7 subvariant has doubled its incidence nationally from 0.8% to 1.7%.
 
 
 
 
 

Resources

 
 

Make the most out of hybrid conferences

Improve your congress competitive intelligence and cut down costs by 50%

 
 
 

Leading lab instruments provider saves $2M a year

How a new app brings the power of CRM to a leading lab instruments provider’s field service engineers

 
 
 

Optimize Digital Engagement Across the Patient Journey

Improve patient engagement, adherence, and outcomes
 
 
 

Achieving faster formulation for First In Human supplies

Supporting your product development programme through experience, expertise, and efficiency.

 
 
 

Building a Broader Tissue Research Ecosystem

Learn how a centralized platform for pathology images, metadata, and analysis results can connect previously siloed research initiatives and advance our collective understanding of tissue.
 
 
 

Improve Life Sciences Research with AI Workflow Automation

Can an optimized research process--including AI-powered workflow and process automation tools--help get breakthrough drugs to market faster?
 
 
 

An Assay Platform to Evaluate Cytokine Release & T Cell Activation

How can we predict the ability of a preclinical drug to inadvertently cause or intentionally inhibit cytokine secretion and T cell activation

 
 
 

Scaling life sciences companies: Discover resources to support growth and innovation

Read through this library of resources to find out how you can strengthen innovation and efficiency, improve safety and quality, and prioritize resources to support your long-term goals.

 
 
 

Expanding Healthcare Services with Digital Agreement Technology

Read our whitepaper and dive into the way healthcare providers can digitally transform day-to-day work by streamlining costs and increasing agility by removing manual paper burdens.

 
 
 

Revealing better ways to do business with agile analytics

Learn how a private health insurance company uses analytics to deliver exceptional service to its employees and members

 
 
 

Medical Affairs Metamorphosis, Part III: How Medical Affairs is Becoming a Key Hub for Evidence Generation

This paper explores how Medical Affairs is increasingly playing a key leadership role in evidence planning and generation (part 3 in a series).

 
 
 

Plan for scalable process liquid and buffer preparation

Explore how Thermo Scientific’s Process Liquid Preparation Services can help you plan for scalable buffer preparation.

 
 
 

Reduce control arm sizes by up to 22% for HD & ALS RCTs

TwinRCTs require fewer patients and shorten trial timelines for rare neurodegenerative diseases.

 
 
 

Lead the way to the next breakthrough

ZS helps life sciences companies shape the future of medicine by turning healthcare data into transformative insights. Discover the power of R&D innovation

 
 
 
 
 

Events